Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

An Acceptance and Commitment Therapy Psychoeducation Single Session Intervention on Childhood Anxiety for Carers of Children With a Long-Term Health Condition

12. juni 2026 oppdatert av: University of East Anglia

The goal of this feasibility study was to assess the acceptability and feasibility of the ACT-based training package for carers of children with a long-term health condition (LTHC) who also experience anxiety.

The main aims were to answer:

Is the intervention feasible? Is the intervention acceptable?

The secondary aim were to answer:

Does the intervention impact how carers approach and manage their child's anxiety?

Participants completed two questionnaires, prior to watching the online training videos. They were then asked to complete another questionnaire. Two weeks later, participants were contacted via email to complete two questionnaires, one of which was a repeat from prior to completing the training.

Studieoversikt

Status

Fullført

Detaljert beskrivelse

This study aims to evaluate the feasibility and acceptability of a newly developed, single-session, online psychoeducational training designed to support caregivers in managing their child's anxiety associated with their long-term health condition (LTHC). The study also explored preliminary changes in caregiver knowledge and approaches to managing anxiety following the intervention.

This study used a quantitative, within-subjects feasibility design. Caregivers of children aged 5-12 years with a diagnosed long-term health condition were recruited. All participants received the intervention, with no control group.

The intervention consisted of a 22-minute online training package delivered via three videos. The content is based on ACT principles and includes psychoeducation about anxiety, ACT-based metaphors and exercises to consider using with their child. The material in the training was specifically designed to support children with a LTHC, rather than generic support for anxiety.

Participants completed measures prior to the intervention, including a demographic questionnaire and the Parent Attitudes, Beliefs and Understanding about Anxiety (PABUA). Immediately following the training, participants completed a structured feedback questionnaire assessing the acceptability and accessibility of the intervention. Two weeks after completing the training, participants were invited via email to complete follow-up measures, including a repeat of the PABUA and a follow-up feedback questionnaire to assess use and perceived usefulness of the strategies.

Feasibility outcomes include recruitment rates, retention rates, and participant-reported acceptability of the intervention and study procedures. Secondary outcomes include changes in caregiver knowledge, beliefs, and confidence in managing their child's anxiety (measured by the PABUA).

Studietype

Intervensjonell

Registrering (Faktiske)

17

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Norfolk
      • Norwich, Norfolk, Storbritannia, NR4 7UJ
        • University of East Anglia (UEA)

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen
  • Eldre voksen

Tar imot friske frivillige

Nei

Beskrivelse

Inclusion Criteria:

  • Primary care giver of children aged 5-12 years
  • The child has a long term health condition (LTHC)

Exclusion Criteria:

  • Carers of children with a learning disability or waiting for an assessment for a learning disability, not including ADHD or dyslexia. This does however include Autism.
  • Participants must be over 18
  • Access to their own electronic device
  • Not have sufficient proficiency in spoken English

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: N/A
  • Intervensjonsmodell: Enkeltgruppeoppdrag
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Single Group
All participants completed the intervention package. The intervention was made up of 3 online training videos lasted a total of 22 minutes.
The intervention was made up of 3 videos, totalling 22 minutes. The videos incorporated psychoeducation on anxiety and Acceptance and Commitment Therapy (ACT) based skills for carers to consider using to support their child with anxiety. All material was based on children with long term health conditions.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Structured Feedback Questionnaire
Tidsramme: Immediately post-intervention
Measure to assess the acceptability and feasibility of the training, for example assessing the consent process and format of the training. The measure uses a scale of strongly disagree (1) to strongly agree (5).
Immediately post-intervention
Follow-up Structured Feedback Questionnaire
Tidsramme: 2-week follow-up
Measure to assess barriers to engaging with the strategies since the training and reviewing usefulness of the strategies used. The measure uses a scale of strongly disagree (1) to strongly agree (5).
2-week follow-up

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Parent, Attitudes, Beliefs and Understanding about Anxiety (PABUA) (Wolk et al, 2016)
Tidsramme: Pre-intervention and 2-week follow-up
The measure was designed to evaluate parental beliefs about their child's anxiety, as well as their perceived ability to cope and manage their child's anxiety. The measure uses a scale of strongly disagree (1) to strongly agree (5).
Pre-intervention and 2-week follow-up

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Studiestol: Kiki Mastroyannopoulou, Senior Fellow of HEA, University of East Anglia (UEA)

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

21. oktober 2025

Primær fullføring (Faktiske)

12. februar 2026

Studiet fullført (Faktiske)

12. februar 2026

Datoer for studieregistrering

Først innsendt

6. mai 2026

Først innsendt som oppfylte QC-kriteriene

12. juni 2026

Først lagt ut (Faktiske)

18. juni 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

18. juni 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

12. juni 2026

Sist bekreftet

1. mars 2026

Mer informasjon

Begreper knyttet til denne studien

Ytterligere relevante MeSH-vilkår

Andre studie-ID-numre

  • Harriet Leader-White

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

IPD-planbeskrivelse

Individual participant data will not be shared due to the sensitive nature of the data and potential risk of identification due to the small sample size.

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere